Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$2.30 +0.04 (+1.77%)
As of: Oct 21, 2026 · 2:08 PM EDT

Eledon Pharmaceuticals (ELDN) Restructuring Costs (2020)

Updated

Eledon Pharmaceuticals (ELDN) recorded Restructuring Costs of $2.3 million in FY2021, up 0.8% from $2.28 million in FY2020.

Analysis

Eledon Pharmaceuticals (ELDN) Restructuring Costs (2020) Analysis & Trends

  • Per Business Quant data, ELDN's Restructuring Costs was $2.28 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.90 Bn 1,102.48 Bn 19.71 Bn
2 Johnson & Johnson 616.46 Bn 534.99 Bn 17.26 Bn
3 AbbVie 501.26 Bn 474.37 Bn 12.70 Bn
4 Merck 367.00 Bn 321.38 Bn 12.21 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 235.82 Bn 191.22 Bn 7.24 Bn
8 Gilead Sciences 190.63 Bn 164.82 Bn 6.22 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn
10 Eledon Pharmaceuticals 261.35 Mn 172.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -10,000.00
Sep 30, 2020 1.80 Mn
Jun 30, 2020 490,000.00
API Access

Eledon Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ELDN&period=max&api_key=YOUR_API_KEY